Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd has filed a compliance disclosure under SEBI Regulation 32(1) regarding the use of proceeds from any past public issue, rights issue, preferential issue, or qualified institutional placement (QIP). The company confirmed that it has no unutilized funds outstanding as of 30 September 2025, meaning there are no leftover funds from any past fund-raising activity that need to be tracked or accounted for. Because there are no unutilized proceeds, the company is not submitting the usual Annexure-A that lists how funds were deployed versus what was originally planned. This is a routine quarterly/half-yearly compliance filing required by SEBI, and the chairperson Umesh Kumar has signed off on it.
This is a neutral, routine compliance filing with no new financial information for shareholders. It simply confirms that the company has no idle money sitting from past fund raises, indicating either that prior issues were fully deployed or that no major public fund-raises have occurred. No action is required from investors.